Patents Examined by Terry A. McKelvey
  • Patent number: 11969447
    Abstract: A composition for promoting defecation includes a cell culture of at least one lactic acid bacterial strain which is substantially free of cells. The least one lactic acid bacterial strain is selected from the group consisting of Lactobacillus salivarius subsp. salicinius AP-32, Bifidobacterium animalis subsp. lactis CP-9, and Lactobacillus acidophilus TYCA06, which are respectively deposited at the Bioresource Collection and Research Center (BCRC) under accession numbers BCRC 910437, BCRC 910645 and BCRC 910813. Also disclosed is a method for promoting defecation, including administering to a subject in need thereof an effective amount of the composition.
    Type: Grant
    Filed: March 17, 2021
    Date of Patent: April 30, 2024
    Assignee: GLAC BIOTECH CO., LTD.
    Inventors: Hsieh-Hsun Ho, Ching-Wei Chen, Yi-Wei Kuo, Yu-Fen Huang, Cheng-Chi Lin
  • Patent number: 11951145
    Abstract: The present invention relates to a composition for preventing or treating cancer, comprising extracts of Anemone raddeana and Lonicera species containing a high concentration of antitumor saponins, and a method for preparing the same, wherein saponins contained in the extracts of Anemone raddeana and Lonicera species, are converted to anticancer saponins having high antitumor activity, thereby producing extracts containing a high concentration of the antitumor saponins, and the extracts thus prepared have been confirmed to show desirable antitumor activity. Accordingly, the extracts containing a high concentration of antitumor saponins of the present invention are promising for use in the development of drugs for cancer treatment.
    Type: Grant
    Filed: March 12, 2019
    Date of Patent: April 9, 2024
    Inventor: Ju Youn Back
  • Patent number: 11944649
    Abstract: Provided herein are compositions, uses thereof, and methods for treating Autism or Autism Spectrum Disorder (ASD) in a subject in need thereof, wherein the compositions comprise a whey protein isolate and/or whey protein concentrate.
    Type: Grant
    Filed: July 31, 2018
    Date of Patent: April 2, 2024
    Assignee: IMMUNOTEC INC.
    Inventor: Ana Maria Castejon Semidey
  • Patent number: 11944661
    Abstract: The present invention provides a pharmaceutical composition for prevention or treatment of a stress disease and depression, the pharmaceutical composition be safely useable without toxicity and side effects by using an extract of leaves of Vaccinium bracteatum Thunb., which is natural resource of Korea, so that the reduction of manufacturing and production costs and the import substitution and export effects can be expected through the replacement of a raw material for preparation with a plant inhabiting in nature.
    Type: Grant
    Filed: February 7, 2018
    Date of Patent: April 2, 2024
    Assignee: JEONNAM BIOINDUSTRY FOUNDATION
    Inventors: Chul Yung Choi, Dool Ri Oh, Yu Jin Kim, Eun Jin Choi, Hyun Mi Lee, Dong Hyuck Bae, Kyo Nyeo Oh, Myung-A Jung, Ji Ae Hong, Kwang Su Kim, Hu Won Kang, Jae Yong Kim, Sang O Pan, Sung Yoon Park, Rack Seon Seong
  • Patent number: 11938161
    Abstract: The present disclosure belongs to the technical field of health care products or foods and provides the use of a ginseng alcohol extract in sleep-promoting health care products or foods. Through analysis utilizing DAM2 drosophila behavior monitoring system, it is found that the ginseng alcohol extract can increase total sleep duration of normal and sleep deprived drosophilae, and relieve sleep rhythm disorder caused by sleep deprivation. Through a climbing experiment, it is found that the ginseng alcohol extract can improve the climbing ability of normal and sleep deprived drosophilae. The ginseng alcohol extract, on the one hand, improves the quality of sleep to protect the steady state of sleep rhythm, and on the other hand, increases the motive ability after sleep. The ginseng alcohol extract of the present disclosure is intended to be used to sleep-promoting health care products or healthy foods and improve the quality of sleep.
    Type: Grant
    Filed: December 23, 2021
    Date of Patent: March 26, 2024
    Inventor: Liwei Sun
  • Patent number: 11930834
    Abstract: Methods of extraction of one or more polyphenolic compounds from pomace are described. The invention also provides uses of the extracts in the fortification of fruit juice, vegetable juice and foods, and as an antioxidant, an anti-inflammatory and an antifungal.
    Type: Grant
    Filed: May 1, 2015
    Date of Patent: March 19, 2024
    Inventor: Vincent Candrawinata
  • Patent number: 11931389
    Abstract: The present invention provides a tablet of sporoderm-removed Ganoderma lucidum spore, which includes the following raw materials by weight parts: 13-20 parts of an aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, 3-5 parts of sorbitol, and 0.8-1.2 parts of povidone K30; A method for preparing the tablet of sporoderm-removed Ganoderma lucidum spore includes the following steps: mixing the aqueous extract of sporoderm-disrupted Ganoderma lucidum spore powder, sorbitol and povidone K30 for 10-30 min, and subjecting the obtained mixture to granulating, screening and drying to obtain a granular material; and tableting the granular material to obtain the tablet of sporoderm-removed Ganoderma lucidum spore. The tablet of sporoderm-removed Ganoderma lucidum spore has a much higher content of active components, which are also easier to be absorbed.
    Type: Grant
    Filed: February 6, 2018
    Date of Patent: March 19, 2024
    Assignees: Zhejiang Shouxiangu Pharmaceutical Company, Ltd., Jinhua Shouxiangu Pharmaceutical Co. Ltd
    Inventors: Zhenhao Li, Mingyan Li, Ying Wang, Huaxian Zheng, Jing Xu
  • Patent number: 11931394
    Abstract: In one embodiment, the present application provides an herbal supplement and method for treating bloating, constipation and/or weight gain in a human subject comprising orally administering to a subject in need thereof an effective amount of the herbal supplement comprising a red quebracho extract. In other embodiments, the supplement may additionally include a triterpenoid saponin, an anti-spasmodic agent, or both.
    Type: Grant
    Filed: February 5, 2021
    Date of Patent: March 19, 2024
    Assignee: KBS RESEARCH, LLC
    Inventors: Kenneth Brown, Brandi M. Scott
  • Patent number: 11925665
    Abstract: Disclosed an extract that is effective in treating drug addiction and a preparation method therefor. An effective component of the extract has the following chemical structural characteristics: a cholestenol compound with hydroxyl (OH) at position 3 and a double bond between position 5 and position 6, or a cholestenol compound with hydroxyl (OH) at position 3, a double bond between position 5 and position 6 and a double bond between position 22 and position 23. The extract can be extracted from the traditional Chinese medicine Agriolima agrestis. The extract of the present invention is safe in acute toxicity, sedative and hypnotic without physical and psychic dependence, has an inhibitory effect on excitability in mouse caused by morphine and benzedrine and a detoxification treatment effect on the withdrawal symptoms in morphine-dependent rats, and is useful in the development of medications or food for treating drug addiction.
    Type: Grant
    Filed: May 25, 2020
    Date of Patent: March 12, 2024
    Assignee: GUANGXI JIUFU BIOTECHNOLOGY CO., LTD
    Inventor: Jun Ruan
  • Patent number: 11911417
    Abstract: A nerve growth promoter and an antioxidant containing a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease. A would treatment agent containing an ethyl acetate extract of a degradation product obtained by degrading a composition containing a hyaluronic acid and a protein with a protease.
    Type: Grant
    Filed: March 8, 2021
    Date of Patent: February 27, 2024
    Assignee: LAIMU CORPORATION
    Inventors: Sachio Wakayama, Akihiro Tai
  • Patent number: 11903990
    Abstract: A method of diminishing the appearance of or effecting the removal or disappearance of seborrheic keratoses by the application of compositions containing a) one or more, preferably a combination of, dietary antioxidants and/or antioxidant sources, b) one or more hydrating agents and c) one or more keratolytic agents.
    Type: Grant
    Filed: January 15, 2022
    Date of Patent: February 20, 2024
    Inventor: William Van Dover Stoecker
  • Patent number: 11903922
    Abstract: Provided are compositions comprising compounds or precursors to compounds which may be used for a variety of therapeutic applications including, for example, treating and/or preventing a disease or disorder related to reduced or inadequate mitochondrial activity, including aging or stress, diabetes, obesity, and neurodegenerative diseases. The compounds relate generally to urolithins and precursors thereof, including but not limited to ellagitannins and urolithin A. In certain embodiments the compositions are presented in or as food products or nutritional supplements. These same compounds and compositions can also be used advantageously in generally healthy individuals to increase or maintain metabolic rate, decrease percent body fat, increase or maintain muscle mass, manage body weight, improve or maintain mental performance (including memory), improve or maintain muscle performance, improve or maintain mood, and manage stress.
    Type: Grant
    Filed: July 14, 2020
    Date of Patent: February 20, 2024
    Assignee: Amazentis SA
    Inventors: Christopher Rinsch, William Blanco-Bose, Bernard Schneider, Charles Thomas, Carmen Sandi, Johan Auwerx, Penelope Andreux, Richardus Houtkooper, Eija Pirinen, Laurent Mouchiroud, David Genoux
  • Patent number: 11872260
    Abstract: This disclosure is directed to essential oils, and methods of their use in treating skin conditions. The skin conditions include those involving HRASQ61L mutant keratinocyte activity, wherein the essential oil inhibits said activity to treat and/or prevent skin cancer. Particularly, the present invention denotes to and composition for inhibiting and prevent skin carcinogenesis or BRAF inhibitor, a type of anti-cancer drug induced cutaneous side effect.
    Type: Grant
    Filed: September 27, 2019
    Date of Patent: January 16, 2024
    Assignee: ACADEMIA SINICA
    Inventors: Lie-Fen Shyur, Chih-Ting Chang, Yuhsin Chen
  • Patent number: 11865106
    Abstract: The invention provides novel pharmaceutical compositions of berberine or a derivative or analog of berberine, or a salt thereof, in combination with one or more omega-3 fatty acids or esters thereof, and methods of their use in treating inflammatory bowel disease.
    Type: Grant
    Filed: August 8, 2018
    Date of Patent: January 9, 2024
    Assignee: SHENZHEN HIGHTIDE BIOPHARMACEUTICAL, LTD.
    Inventor: Liping Liu
  • Patent number: 11865121
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: February 8, 2017
    Date of Patent: January 9, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Patent number: 11857578
    Abstract: The invention relates to a new bacterial extract that can be used for protecting and/or treating sensitive skin and/or reactive, intolerant skin, particularly by means of targeted action on neurogenic inflammation of the skin. The invention also relates to cosmetic or dermatological compositions comprising such a bacterial extract as an active ingredient.
    Type: Grant
    Filed: May 31, 2019
    Date of Patent: January 2, 2024
    Assignee: PIERRE FABRE DERMO-COSMETIQUE
    Inventors: Nathalie Castex-Rizzi, Bertrand Chol, Fabrice Lestienne
  • Patent number: 11857553
    Abstract: Administration of certain chromium complexes in combination with a starch provide unexpected benefits regarding increasing amino acid absorption, protein synthesis, exercise tolerance, lean muscle mass, skeletal muscle hypertrophy, muscle power, muscle endurance, muscle strength, FSR, and decreasing delayed onset muscle soreness, muscle protein breakdown, and fat mass.
    Type: Grant
    Filed: March 27, 2019
    Date of Patent: January 2, 2024
    Assignee: Nutrition21, LLC
    Inventor: James R. Komorowski
  • Patent number: 11857586
    Abstract: The present invention relates to a composition for prevention or treatment of gynecological diseases containing an extract of Sarcodon imbricatus as an active ingredient. Specifically, the extract of Sarcodon imbricatus of the present invention can be effectively used, with only one dose, for prevention or treatment of gynecological diseases by treating dysmenorrhea, reducing a menstrual period, an amount of menstruation, menstrual irregularity, and extravasated blood, and clearing the color of menstruation.
    Type: Grant
    Filed: October 11, 2022
    Date of Patent: January 2, 2024
    Inventor: Hye Jin Woo
  • Patent number: 11833183
    Abstract: A method for improving body shape and improving skin condition using a noni fruit ferment is provided, and the method includes: administrating a composition to a subject in need thereof. The composition includes an effective amount of noni fruit ferment. The noni fruit ferment is prepared by (a) mixing glucose and noni fruit with water for extraction, to obtain a noni fruit broth, and (b) fermenting the noni fruit broth with a plurality of bacteria strains. The bacteria strains include yeast, lactic acid bacteria, and acetic acid bacteria. In step (b), the noni fruit broth and the bacteria strains are irradiated with a red light source with a wavelength of 620 nm to 750 nm. In addition, the noni fruit ferment also has at least one of the following functions: removing free radicals, improving defecation status, and improving gastrointestinal motility.
    Type: Grant
    Filed: January 27, 2022
    Date of Patent: December 5, 2023
    Assignee: TCI CO., LTD.
    Inventors: Yung-Hsiang Lin, Pei-Yi Wu
  • Patent number: 11806376
    Abstract: A pharmaceutical composition for treating oral ulcer, a preparation method and an application thereof are provided, which belong to the technical field of pharmaceutical compositions. The pharmaceutical composition includes the following raw materials: 20-50 parts of Sanhuang mixture, 15-20 parts of lotus root powder, 30-50 parts of Galla chinensis, 10-20 parts of Lonicera japonica Thunb., 10-20 parts of vanilla bean, 10-20 parts of propolis, 5-8 parts of oak bark, 5-10 parts of tea, 3-5 parts of Asarum, 1-2 parts of Atractylodes macrocephala and 5-30 parts of chlorhexidine acetate. The pharmaceutical composition for treating oral ulcer has the efficacies of clearing away heat, detoxifying removing blood stasis and reducing swelling, promoting granulation and relieving pain, inhibiting bacteria and killing bacteria, and has the advantages of quick response, easy finding of raw materials and low cost, and has a good therapeutic effect for treating oral ulcer clinically.
    Type: Grant
    Filed: March 9, 2022
    Date of Patent: November 7, 2023
    Assignee: SICHUAN TIANFU FINE CHEMICAL CO., LTD.
    Inventors: Chongfu Wang, Kui Wang, Yu Gao